<DOC>
	<DOCNO>NCT03093896</DOCNO>
	<brief_summary>Cognitive impairment also major risk factor development dementia later life . Findings recent study suggest many nutrient contain food may important cognitive function elderly . This study evaluate long-term intervention almonds snack mix treatment strategy age-related cognitive impairment could possibly prevent onset dementia . The propose study design randomize , placebo control trial test effect 6 month supplementation 1.5 3 ounce almonds 3 ounce shortbread contain coconut oil cognitive function old adult . Secondary outcome include plasma biomarkers oxidative stress inflammation .</brief_summary>
	<brief_title>The Effect Consumption Almonds Snack Mix Daily 6 Months Cognitive Function Older Adults</brief_title>
	<detailed_description>The study design control trial test effect 6 month supplementation 1.5 3 ounce almonds 3 ounce snack mix day cognitive function old adult . Subjects randomly assign one three group . Secondary outcome include plasma biomarkers oxidative stress inflammation . Participants recruit community-dwelling men woman age great equal 50 yr less equal 75 year potential participant screen meet cognitive functional criterion . Participants pre-screened telephone ; appear meet criterion undergo screening .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>men woman age &gt; 50 75 year body mass index &gt; 2535 kg/m2 Mini mental state exam ( MMSE ) score &gt; 24 must able give write informed consent history active small bowel disease resection atrophic gastritis uncontrolled blood pressure untreated hypertension alcoholism ( &gt; 2 drinks/d 14 drinks/week ) abnormal hematologic parameter determine study MD influence study outcome . endocrine disorder include diabetes current pharmacological treatment diabetes untreated thyroid disease pancreatic disease anemia , bleed disorder nut allergy major chronic illness might interfere study outcomes active cancer except prostate cancer cancerfree least 5 year unwilling use lutein , n3 fatty acid , choline supplement 2 month prior study start disease interfere fat absorption , e.g . colitis , celiac disease , Crohn 's disease , cystic fibrosis ( determined screen interview ) rheumatologic diseases include gout inflammatory arthritis immune deficiency condition include autoimmune dieases , human immune deficiency virus ( HIV ) ; history organ transplantation medication interfere fat absorption , e.g . bile sequestrants ( determine screen interview ) use antipsychotic , antimanic , antiinflammatory ( except aspirin non steroidal antiinflammatory drug [ NSAIDS ] ) , monoamine inhibitor , dementia medication inability discontinue aspirin , NSAIDS 72 hour prior duration test study visit ( baseline , 3 6 month ) daily intake proton pump inhibitor H2 blocker smoke use nicotine patch gum ( within past 6 month ) use drug suspect interfere metabolism blood clot exception aspirin NSAIDS , e.g . warfarin ( determined screen interview ) stroke , head injury loss consciousness seizure . history clinical manifestation significant neurologic disorder opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>almond</keyword>
	<keyword>cereal snack</keyword>
</DOC>